According to market disclosures, investors building portfolios centered around artificial intelligence can look toward data center providers and memory chip suppliers to capture growth as the technology scales.
Iren Neocloud Strategy and Compute Values
Iren operates within the neocloud sector by building data centers that supply hyperscalers with chips, power, software, and facilities, according to company data. The firm reported $1 billion in operating annual recurring revenue at the close of its fiscal 2026 fourth quarter and projects reaching $4 billion by the end of 2026. Compute values continue to climb while Iren strategically waits to sign major agreements. For comparison, the firm’s landmark five-year, $9.7 billion deal with Microsoft equates to $9.7 million per megawatt-year, while current negotiations target $25 million per megawatt.
If Iren realizes $25 million per megawatt across its 5.8-gigawatt portfolio, it could generate $145 billion in annual recurring revenue at current per-megawatt values. To fund capital expenditures without heavy dilution, Iren requires customers to prepay 45% to 55% of each contract, alongside utilizing GPU financing and borrowing against its data center assets.
Did you know? Iren requires customers to prepay between 45% and 55% of each contract, a strategy designed to fund data center builds while minimizing shareholder dilution.
Netlist Patent Portfolio and Samsung Agreement
Netlist maintains a market cap of approximately $2 billion and develops CXL solutions for future AI infrastructure while reselling memory products, according to market summaries. The company secured a strategic agreement with Samsung following a patent infringement legal battle. Under the terms, Samsung agreed to pay an up-front licensing fee of $239 million alongside quarterly royalty payments of up to $32.9 million over five years. Additionally, Netlist gained the right to purchase up to $300 million in Samsung memory products annually for five years.
The total five-year contract can reach up to $897 million in gross license revenue, providing substantial profit while reducing ongoing legal expenditures. Netlist is pursuing similar legal actions against Micron Technology. Although Netlist recently lost an appeal in a patent case against Micron—causing a more than 20% drop in share price—that ruling involved patents separate from the critical ones leveraged in the Samsung settlement, leaving a separate $445 million patent infringement case active against Micron.
Comparing Neocloud and Infrastructure Investments
Evaluating AI infrastructure requires examining different business models within the ecosystem. Iren focuses on large-scale data center capacity and power delivery for hyperscalers, scaling its annual recurring revenue toward multi-billion-dollar targets. In contrast, Netlist focuses on smaller-scale memory solutions and patent monetization, deriving immediate upside from licensing agreements and supply rights with major manufacturers like Samsung.
| Company | Market Focus | Key Financial Metric |
|---|---|---|
| Iren | Neocloud data centers & compute power | Targeting $4B ARR by end of 2026 |
| Netlist | CXL solutions, memory, & patent licensing | Up to $897M gross license revenue via Samsung deal |
Frequently Asked Questions
What is the neocloud business model?
Neocloud companies build and operate data centers that supply hyperscalers with the necessary chips, power, software, and physical facilities required for artificial intelligence workloads.
How does Iren fund its data center construction?
Iren secures prepayments of 45% to 55% from customers on each contract, utilizes GPU financing, and borrows against its data center assets to avoid equity dilution.
What are the terms of Netlist’s agreement with Samsung?
Samsung pays a $239 million up-front licensing fee, quarterly royalties of up to $32.9 million for five years, and grants Netlist the right to buy up to $300 million in memory products annually.
Join the Discussion
What are your thoughts on investing in AI infrastructure versus memory and patent stocks? Leave a comment below or share this article with fellow investors.